AIA Group Ltd Purchases 5,475 Shares of Xylem Inc. $XYL

AIA Group Ltd grew its holdings in shares of Xylem Inc. (NYSE:XYL) by 108.1% during the first quarter, according to the company in its most recent disclosure with the SEC. The fund owned 10,539 shares of the industrial products company’s stock after buying an additional 5,475 shares during the quarter. AIA Group Ltd’s holdings in Xylem were worth $1,259,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. AQR Capital Management LLC boosted its stake in shares of Xylem by 14.4% during the first quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after purchasing an additional 3,900 shares during the period. NewEdge Advisors LLC increased its stake in Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after buying an additional 132 shares during the period. Empowered Funds LLC lifted its holdings in Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after buying an additional 3,120 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in Xylem by 97.6% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after buying an additional 5,509 shares in the last quarter. Finally, EverSource Wealth Advisors LLC boosted its position in Xylem by 114.0% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock valued at $154,000 after buying an additional 635 shares during the period. 87.96% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on XYL shares. CLSA upgraded shares of Xylem to a “hold” rating in a research note on Thursday, June 25th. Weiss Ratings downgraded shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research note on Friday, May 8th. Barclays dropped their price objective on Xylem from $156.00 to $154.00 and set an “overweight” rating on the stock in a research note on Wednesday, April 29th. UBS Group raised their price objective on Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Finally, Jefferies Financial Group raised Xylem from a “hold” rating to a “buy” rating and lifted their target price for the company from $130.00 to $140.00 in a research report on Thursday, June 25th. Eight equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $153.15.

Insider Activity

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the sale, the chief accounting officer owned 3,605 shares of the company’s stock, valued at approximately $423,443.30. The trade was a 54.22% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jerome A. Peribere acquired 1,210 shares of the company’s stock in a transaction dated Monday, May 4th. The shares were bought at an average cost of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.

Xylem Price Performance

NYSE XYL opened at $120.82 on Tuesday. The company has a market cap of $28.72 billion, a PE ratio of 30.05, a P/E/G ratio of 1.75 and a beta of 1.03. The firm’s 50 day moving average price is $113.40 and its 200-day moving average price is $123.26. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.10 and a current ratio of 1.46. Xylem Inc. has a 52-week low of $105.29 and a 52-week high of $154.27.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.09 by $0.03. Xylem had a net margin of 10.79% and a return on equity of 11.26%. The company had revenue of $2.12 billion during the quarter, compared to the consensus estimate of $2.11 billion. During the same quarter in the previous year, the firm posted $1.03 earnings per share. Xylem’s revenue for the quarter was up 2.7% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. Sell-side analysts forecast that Xylem Inc. will post 5.51 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 25th. Stockholders of record on Thursday, May 28th were issued a dividend of $0.43 per share. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a dividend yield of 1.4%. Xylem’s dividend payout ratio is 42.79%.

Xylem Company Profile

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.